Brief: Liminal Biosciences Announces Strategic Priorities For 2022
19/01/2022 21:41
Jan 19 (Reuters) - Liminal BioSciences Inc LMNL.O :
* LIMINAL BIOSCIENCES ANNOUNCES STRATEGIC PRIORITIES FOR
2022
* LIMINAL BIOSCIENCES INC- EXPECTS TO BE ABLE TO FINALISE
CANDIDATE SELECTION FOR ITS OXER-1 PROGRAM IN 2023 TO PROGRESS
TO CLINIC
Source text for Eikon: ID:nPn6CRj1ba
Further company coverage: LMNL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Liminal BioSciences
See all newsBrief: Liminal Biosciences Announces Completion Of The Plan Of Arrangement With Structured Alpha Lp
Brief: Liminal Biosciences Files Amended Schedule 13E-3 And Supplement To Management Information Circular
Brief: Liminal Biosciences Obtains Interim Order For Proposed Arrangement With Structured Alpha Lp
U.S. STOCKS ON THE MOVE-Liminal Biosciences, Tesla, Quad/Graphics
U.S. STOCKS ON THE MOVE-T2 Biosystems, GoodRx Holdings, ShiftPixy